Free Alerts   Login
Consumer Staples › SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

SKIN Stock Price Correlated With Beauty Health Co Financials

SKIN Stock Price vs. Quarterly
SKIN
Income Statement
Cash Flow
Balance Sheet

SKIN Income Statement

Enable JavaScript and reload
Revenue, Net:
Revenue Per Share:
Cost of Goods & Services Sold:
Gross Profit:
Selling, General & Admin Expense:
Research & Development Expense:
Total Operating Expenses:
Operating Income:
Income Taxes:
Net Income:
Earnings Per Share, Diluted:
Earnings Per Share, Basic:
Shares Outstanding, Basic Avg:
Shares Outstanding, Diluted Avg:
Common Stock Shares Outstanding:

SKIN Cash Flow

Enable JavaScript and reload
Operating Activities Net Income:
Depreciation, Depletion & Amortization:
Change in Accounts Receiveable:
Net Cash from Operations:
Net Cash from Operations Per Share:
Repurchases/Buybacks Common Stock:
Issuance of Long-term Debt:
Cash Dividends Paid:
Net Cash from Financing Activities:
Property, Plant & Equipment Purchases:
Purchases of Businesses, Net of Cash:
Net Cash from Investing Activities:
Net Change in Cash & Equivalents:

SKIN Balance Sheet

Enable JavaScript and reload
Cash and Cash Equivalents:
Short-Term Investments:
Accounts Receivable, Net:
Inventories:
Total Current Assets:
Property, Plant & Equipment, Net:
Total Assets:
Accounts Payable:
Current Portion of Long-Term Debt:
Total Short-Term Liabilities:
Long Term Debt, Non-Current Portion:
Total Long-Term Liabilities:
Total Liabilities:

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
FMR
16,786,185 sh
-3,146,680 sh
-16%
$52,205
-$67,792
Janus Henderson Group Plc
11,299,927 sh
-267,266 sh
-2%
$35,143
-$34,492
Vanguard Group
7,258,870 sh
-1,554,711 sh
-18%
$22,575
-$30,483
Luxor Capital Group, Lp
6,587,139 sh
6,087,139 sh
1217%
$20,486
$17,476
Morgan Stanley
6,290,255 sh
5,833,812 sh
1278%
$19,563
$16,816
Blackrock.
6,175,588 sh
-1,410,606 sh
-19%
$19,206
-$26,463
Camber Capital Management Lp
3,500,000 sh
-1,500,000 sh
-30%
$10,885
-$19,215
Point72 Asset Management, L.P.
2,279,501 sh
2,279,501 sh
NEW
$7,089
$7,089
Geode Capital Management
1,875,626 sh
70,729 sh
4%
$5,834
-$5,033
State Street
1,758,354 sh
44,147 sh
3%
$5,468
-$4,852
Ararat Capital Management, Lp
1,741,382 sh
1,741,382 sh
NEW
$5,416
$5,416
Silver Point Capital
1,592,030 sh
 
$4,889
Millennium Management
1,089,522 sh
866,882 sh
389%
$3,388
$2,048
Arrowmark Colorado Holdings
834,474 sh
-846,279 sh
-50%
$2,595
-$7,523
Portolan Capital Management
821,688 sh
821,688 sh
NEW
$2,555
$2,555
Northernrp
783,308 sh
24,180 sh
3%
$2,436
-$2,134
Citadel Advisors
777,091 sh
652,291 sh
523%
$2,417
$1,666
DARK FOREST CAPITAL MANAGEMENT
657,169 sh
280,055 sh
74%
$2,044
-$226
Jane Street Group
646,050 sh
414,749 sh
179%
$2,010
$74
Glendon Capital Management Lp
636,954 sh
 
$1,981
COMPANY PROFILE
Description of Business The Beauty Health Company, formerly known as Vesper Healthcare Acquisition Corp. (the “Company” or “BeautyHealth”), was incorporated in Delaware on July 8, 2020. The Company was originally formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

On May 4, 2021 (the “Closing Date”), the Company consummated the previously announced business combination pursuant to that certain Agreement and Plan of Merger, dated December 8, 2020 (the “Merger Agreement”), by and among Vesper Healthcare Acquisition Corp. (“Vesper”), Hydrate Merger Sub I, Inc. (“Merger Sub I”), Hydrate Merger Sub II, LLC (“Merger Sub II”), LCP Edge Intermediate, Inc., the indirect parent of Edge Systems LLC d/b/a The HydraFacial Company (“HydraFacial”), and LCP Edge Holdco, LLC (“LCP,” or “Former Parent,” and, in its capacity as the stockholders’ representative, the “Stockholders’ Representative”), which provided for: (a) the merger of Merger Sub I with and into HydraFacial, with HydraFacial continuing as the surviving corporation (the “First Merger”), and (b) immediately following the First Merger and as part of the same overall transaction as the First Merger, the merger of HydraFacial with and into Merger Sub II, with Merger Sub II continuing as the surviving entity (the “Second Merger” and, together with the First Merger, the “Mergers” and, together with the other transactions contemplated by the Merger Agreement, the “Business Combination”). As a result of the First Merger, the Company owns 100% of the outstanding common stock of HydraFacial and each share of common stock and preferred stock of HydraFacial has been cancelled and converted into the right to receive a portion of the consideration payable in connection with the Mergers. As a result of the Second Merger, the Company owns 100% of the outstanding interests in Merger Sub II. In connection with the closing of the Business Combination (the “Closing”), the Company owns, directly or indirectly, 100% of the stock of HydraFacial and its subsidiaries and the stockholders of HydraFacial as of immediately prior to the effective time of the First Merger (the “HydraFacial Stockholders”) hold a portion of the Company’s Class A Common Stock, par value $0.0001 per share (the “Class A Common Stock”).

In connection with the Closing, the Company changed its name from “Vesper Healthcare Acquisition Corp.” to “The Beauty Health Company.” Following the Closing, on May 6, 2021, the Company’s Class A Common Stock and publicly traded warrants were listed on the Nasdaq Capital Market (“Nasdaq”) under the symbols, “SKIN” and “SKINW”, respectively. The transactions set forth in the Merger Agreement constitute a “Business Combination” as contemplated by Vesper’s Second Amended and Restated Certificate of Incorporation.

Unless the context otherwise requires, in this Quarterly Report on Form 10-Q, the “Company” refers to Vesper Healthcare Acquisition Corp. prior to the closing of the Business Combination and to the combined company and its subsidiaries following the Closing and “HydraFacial” refers to the business of LCP Edge Intermediate, Inc. and its subsidiaries prior to the Closing. References to “Vesper” refer to Vesper Healthcare Acquisition Corp. prior to the consummation of the Business Combination.

The Company is a category-creating beauty health company focused on bringing innovative products to market. The Company and its subsidiaries design, develop, manufacture, market, and sell a/esthetic technologies and products. The Company’s flagship brand, HydraFacial, is a non-invasive and approachable beauty health platform and ecosystem. HydraFacial uses a unique delivery system to cleanse, extract, and hydrate with their patented hydradermabrasion technology and serums that are made with nourishing ingredients.

The COVID-19 pandemic has had, and may continue to have a

Free historical financial statements for Beauty Health Co.. See how revenue, income, cash flow, and balance sheet financials have changed over 11 quarters since 2021. Compare with SKIN stock chart to see long term trends.

Data imported from Beauty Health Co. SEC filings. Check original filings before making any investment decision.